| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGCCCGGAGCCUGCAGCCCAGCCCCACCCAGACCCAUGGCUGGACCUGC… | 1513 nt | 0.5942 | |
| AGCCCGGAGCCUGCAGCCCAGCCCCACCCAGACCCAUGGCUGGACCUGC… | 1396 nt | 0.5874 | |
| AGCCCGGAGCCUGCAGCCCAGCCCCACCCAGACCCAUGGCUGGACCUGC… | 1504 nt | 0.5944 | |
| AGCCCGGAGCCUGCAGCCCAGCCCCACCCAGACCCAUGGCUGGACCUGC… | 1405 nt | 0.5872 |
This gene encodes a member of the IL-6 superfamily of cytokines. The encoded cytokine controls the production, differentiation, and function of granulocytes. Granulocytes are a type of white blood cell that are part of the innate immune response. A modified form of this protein is commonly administered to manage chemotherapy-induced neutropenia. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2020]
A study in Sprague-Dawley rats demonstrated that the CSF3 gene, identified as a differentially expressed mRNA in skeletal muscle contusion, was included in multiple index gene sets (A, C, and D) for wound age estimation [Ren et al. DOI:10.1016/j.fsigen.2022.102722]. In human skin, research on thermal injuries found the CSF3 gene was significantly up-regulated in burned tissue compared to normal skin, as part of an extensive inflammatory and immune response during wound repair [Greco et al. DOI:10.1016/j.burns.2009.06.211]. A study in human burn patients demonstrated that circulating concentrations of the CSF3 were significantly increased immediately (0-3 days) postburn compared to controls, then subsequently dropped [Knuth et al. DOI:10.1097/SLA.0000000000005880].